240 related articles for article (PubMed ID: 15872096)
1. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.
Zhou R; Gray NA; Yuan P; Li X; Chen J; Chen G; Damschroder-Williams P; Du J; Zhang L; Manji HK
J Neurosci; 2005 May; 25(18):4493-502. PubMed ID: 15872096
[TBL] [Abstract][Full Text] [Related]
2. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage.
Bachmann RF; Wang Y; Yuan P; Zhou R; Li X; Alesci S; Du J; Manji HK
Int J Neuropsychopharmacol; 2009 Jul; 12(6):805-22. PubMed ID: 19149911
[TBL] [Abstract][Full Text] [Related]
3. Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression.
Du J; Gray NA; Falke CA; Chen W; Yuan P; Szabo ST; Einat H; Manji HK
J Neurosci; 2004 Jul; 24(29):6578-89. PubMed ID: 15269270
[TBL] [Abstract][Full Text] [Related]
4. Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Lasoń W
Eur J Pharmacol; 2004 Jul; 495(2-3):103-10. PubMed ID: 15249158
[TBL] [Abstract][Full Text] [Related]
5. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
6. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.
Einat H; Yuan P; Gould TD; Li J; Du J; Zhang L; Manji HK; Chen G
J Neurosci; 2003 Aug; 23(19):7311-6. PubMed ID: 12917364
[TBL] [Abstract][Full Text] [Related]
7. Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression.
Du J; Gray NA; Falke C; Yuan P; Szabo S; Manji HK
Ann N Y Acad Sci; 2003 Nov; 1003():378-80. PubMed ID: 14684466
[TBL] [Abstract][Full Text] [Related]
8. Bag-1M is a component of the in vivo DNA-glucocorticoid receptor complex at hormone-regulated promoter.
Hong W; Baniahmad A; Liu Y; Li H
J Mol Biol; 2008 Dec; 384(1):22-30. PubMed ID: 18822299
[TBL] [Abstract][Full Text] [Related]
9. Bag-1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience.
Luo S; Hou Y; Zhang Y; Feng L; Hunter RG; Yuan P; Jia Y; Li H; Wang G; K Manji H; S McEwen B; Xiao C; Bao H; Du J
J Neurochem; 2021 Jul; 158(2):358-372. PubMed ID: 33025573
[TBL] [Abstract][Full Text] [Related]
10. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.
Asghari V; Wang JF; Reiach JS; Young LT
Brain Res Mol Brain Res; 1998 Jul; 58(1-2):95-102. PubMed ID: 9685595
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
13. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
14. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
15. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.
Hao Y; Creson T; Zhang L; Li P; Du F; Yuan P; Gould TD; Manji HK; Chen G
J Neurosci; 2004 Jul; 24(29):6590-9. PubMed ID: 15269271
[TBL] [Abstract][Full Text] [Related]
16. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
17. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
Corrêa C; Amboni G; Assis LC; Martins MR; Kapczinski F; Streck EL; Quevedo J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):887-91. PubMed ID: 17367908
[TBL] [Abstract][Full Text] [Related]
18. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386
[TBL] [Abstract][Full Text] [Related]
19. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Chen G; Manji HK
Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
[TBL] [Abstract][Full Text] [Related]
20. Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life?
Yuan P; Salvadore G; Li X; Zhang L; Du J; Chen G; Manji HK
Bipolar Disord; 2009 May; 11(3):256-69. PubMed ID: 19419383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
